Literature DB >> 31228131

Quality of Life Following Major Laparoscopic or Open Pancreatic Resection.

Robert J Torphy1, Brandon C Chapman1, Chloe Friedman1, Christina Nguyen1, Christan G Bartsch1, Cheryl Meguid1, Steven A Ahrendt1, Martin D McCarter1, Marco Del Chiaro1, Richard D Schulick1, Barish H Edil2, Ana Gleisner3.   

Abstract

PURPOSE: This study was designed to compare quality of life (QoL) among patients who underwent open versus laparoscopic pancreatic resection, including distal pancreatectomy and pancreaticoduodenectomy, and to identify clinical characteristics that are associated with changes in QoL.
METHODS: Quality of life (QoL) was assessed in patients undergoing pancreatic resection with the Functional Assessment of Cancer Therapy-Hepatobiliary questionnaire preoperatively and 2 weeks, 1, 3, and 6 months postoperatively. Multilevel regression modeling was used to determine the variability in each QoL domain within the first 2 weeks (postoperative period) and thereafter (recovery period).
RESULTS: Among 159 patients, 60.4% underwent open and 39.6% underwent laparoscopic surgery. Physical, functional, hepatobiliary, and total QoL scores decreased in the postoperative period but returned to baseline levels by 6 months postoperatively. Emotional QoL improved from baseline by 2 weeks after surgery (p < 0.001) and social QoL improved from baseline by 3 months after surgery (p < 0.001). Emotional QoL was the only domain where significant differences were observed in QoL in the postoperative and recovery periods between patients who underwent open and laparoscopic pancreatic resection. Controlling for surgical approach, patients who experienced a grade III or IV complication experienced greater declines in physical, functional, hepatobiliary, and total QoL in the postoperative period. The negative impact of complications on QoL resolved by 6 months postoperatively.
CONCLUSIONS: The impact of pancreatic resection on QoL was comparable between patients who underwent laparoscopic versus open pancreatic resection. Complications were strongly associated with changes in postoperative QoL, suggesting that performing a safe operation is the best approach for optimizing patient reported QoL.

Entities:  

Mesh:

Year:  2019        PMID: 31228131     DOI: 10.1245/s10434-019-07449-x

Source DB:  PubMed          Journal:  Ann Surg Oncol        ISSN: 1068-9265            Impact factor:   5.344


  4 in total

1.  Preoperative Nomogram Predicts Non-home Discharge in Patients Undergoing Pancreatoduodenectomy.

Authors:  Katelyn F Flick; C Max Schmidt; Cameron L Colgate; Michele T Yip-Schneider; Chris M Sublette; Thomas K Maatman; Mazhar Soufi; Eugene P Ceppa; Michael G House; Nicholas J Zyromski; Attila Nakeeb
Journal:  J Gastrointest Surg       Date:  2020-06-24       Impact factor: 3.452

2.  Dynamic prediction for clinically relevant pancreatic fistula: a novel prediction model for laparoscopic pancreaticoduodenectomy.

Authors:  Runwen Liu; Yunqiang Cai; He Cai; Yajia Lan; Lingwei Meng; Yongbin Li; Bing Peng
Journal:  BMC Surg       Date:  2021-01-04       Impact factor: 2.102

3.  Robotic versus Open Pancreatoduodenectomy for Pancreatic and Periampullary Tumors (PORTAL): a study protocol for a multicenter phase III non-inferiority randomized controlled trial.

Authors:  Jiabin Jin; Yusheng Shi; Mengmin Chen; Jianfeng Qian; Kai Qin; Zhen Wang; Wei Chen; Weiwei Jin; Fengchun Lu; Zheyong Li; Zehua Wu; Li Jian; Bing Han; Xiao Liang; Chuandong Sun; Zheng Wu; Yiping Mou; Xiaoyu Yin; Heguang Huang; Hao Chen; Georgios Gemenetzis; Xiaxing Deng; Chenghong Peng; Baiyong Shen
Journal:  Trials       Date:  2021-12-27       Impact factor: 2.279

4.  Possible involvement of HSP70 in pancreatic cancer cell proliferation after heat exposure and impact on RFA postoperative patient prognosis.

Authors:  Hui-Bin Song
Journal:  Biochem Biophys Rep       Date:  2019-10-31
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.